You have to think beyond a patient's disease process and think about how they engage with the healthcare system, explained Jason Mitchell, MD, chief medical and clinical transformation officer, Presbyterian Healthcare Services.
You have to think beyond a patient's disease process and think about how they engage with the healthcare system, explained Jason Mitchell, MD, chief medical and clinical transformation officer, Presbyterian Healthcare Services.
Transcript
In a fully transitioned value-based care landscape, what are things the healthcare system would be focused on or paying attention to that it isn’t right now?
When you think about really dropping the total cost of care and providing the best healthcare to the people you’re caring for, you’ve got to think of them when they’re not in your hospitals and not in your clinics. What’s going on in their home? What’s going on in their community? What’s your employment look like? Education? Those type of things. I think it really is getting back to those social determinants, getting back to the health of the community, and really thinking about those things as an organization and invest into those things as an organization. I think that’s a lot of the pieces that get left behind, historically.
I think you also have to think beyond someone’s disease process. You have to think about how people engage in healthcare and what their behaviors are so that you can do interventions to help with those types of behaviors and meet their needs. It’s no longer a once-size-fits-all but it’s really how do you give individualized care to an entire population?
The Importance of Examining and Preventing Atrial Fibrillation
August 29th 2023At this year’s American Society for Preventive Cardiology Congress on CVD Prevention, Emelia J. Benjamin, MD, ScM, delivered the Honorary Fellow Award Lecture, “The Imperative to Focus on the Prevention of Atrial Fibrillation,” as the recipient of this year’s Honorary Fellow of the American Society for Preventive Cardiology award.
Listen
Gene and Cell Therapies Hold Potential—but How Can Payers Manage Their Costs?
April 18th 2024Presenters at the Academy of Managed Care Pharmacy (AMCP) 2024 annual meeting discussed the current promise and future potential of gene and cell therapies, as well as payer management strategies for these costly treatments.
Read More
Navigating Medicare's Part D Subsidy Program to Achieve Value-Based Care
May 26th 2023On this episode of Managed Care Cast, we speak with the lead researcher from a study published in the May 2023 issue of The American Journal of Managed Care® about the impact of low-income subsidies on the uptake and equitable use of expensive orally administered antimyeloma therapy.
Listen
Need for Pharmacogenomic Testing in Mental Health Care Explored at AMCP 2024
April 17th 2024Presenters from Mayo Clinic discussed the benefits of implementing pharmacogenomic testing in mental health care for the betterment of patient outcomes, reducing medical costs, and more at the Academy of Managed Care Pharmacy (AMCP) 2024 annual meeting.
Read More